Getting an early diagnosis could potentially improve quality of life and alleviate “healthcare burdens” for people in Taiwan who are…
Michela Luciano, PhD
Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her research focused on the role of inflammation in acute myeloid leukemia. With a deep passion for scientific communication, Michela transitioned into her first role as a scientific writer in 2022. Outside of work, she enjoys street photography, mountain hiking, running, and spending as much time as possible outdoors.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Michela Luciano, PhD
A treatment approved for adults, called Scenesse (afamelanotide), successfully treated a 9-year-old girl with erythropoietic protoporphyria (EPP) and…
PORT-77, an oral small molecule therapy being developed to treat erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), by Gondolabio…
Hundreds of patients in Japan with unexplained abdominal pain go untested for acute hepatic porphyria (AHP), despite showing a number…
The case of a 43-year-old woman with variegate porphyria (VP) who developed acute psychosis despite no prior psychiatric history…
A woman in her 60s with fragile skin and blistering lesions on sun-exposed areas was diagnosed with porphyria cutanea tarda…